A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder
Conditions: Adjunctive Treatment of Major Depressive Disorder (MDD) Interventions: Drug: CLE-100; Drug: Placebo Sponsors: Clexio Biosciences Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of Rejoyn, the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms
PRINCETON, N.J. and NEW YORK, N.Y. (April 1, 2024)– Otsuka Pharmaceutical, Co. Ltd. (Otsuka) and Click Therapeutics, Inc., (Click) announce that the U.S. Food and Drug Administration (FDA) has cleared Rejoyn™ (developed as CT-152), the... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 1, 2024 Category: Pharmaceuticals Source Type: clinical trials
Brief Problem-solving Intervention in Different Formats for the Prevention of Suicide in Adults Over 50
Conditions: Suicide Interventions: Behavioral: Problem-solving-based psychological intervention Sponsors: University of Santiago de Compostela; Ministry of science and innovation of Spain Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 1, 2024 Category: Research Source Type: clinical trials
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
Conditions: Major Depressive Disorder; Schizo Affective Disorder; Schizophrenia; Bipolar Disorder Interventions: Behavioral: Behavior Activation Sponsors: Temple University; National Institute on Disability, Independent Living, and Rehabilitation Research Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
The Effect of Emotional Freedom Technique (EFT) on Depression in Postmenopausal Women
Conditions: Menopause Interventions: Other: emotional liberation technique Sponsors: Gulhane School of Medicine Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
Conditions: All Cause Mortality; Cardiovascular Diseases; Invasive Cancer; Liver Cirrhosis; Type 2 Diabetes; Depression; Dementia; Injury Traumatic; Tuberculosis; Infections Interventions: Behavioral: Moderate Alcohol Drinking Pattern; Behavioral: Abstention Sponsors: Clinica Universidad de Navarra, Universidad de Navarra Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Developing the Precision Nursing Education Program to Young Colorectal Cancer Survivors
Conditions: Depression Interventions: Behavioral: 8-weeks ' s on-line precision nursing education program Sponsors: Fooyin University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants
Conditions: Depression; Inflammation; Antidepressants; Immunity Interventions: Drug: SSRI Sponsors: Germans Trias i Pujol Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2024 Category: Research Source Type: clinical trials
Abbreviated MBCT for Depression in Older African American/Black Breast Cancer Survivors
Conditions: Breast Cancer; Breast Cancer Female; Breast Cancer Stage I; Breast Cancer Stage II; Breast Cancer Stage III; Mild Depression; Moderate Depression Interventions: Other: MBCT Sponsors: Case Comprehensive Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2024 Category: Research Source Type: clinical trials
Standardized Assessment in Depression Treatment in Routine Psychiatric Services
Conditions: Major Depressive Disorder Sponsors: Karolinska Institutet; Region Stockholm Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 27, 2024 Category: Research Source Type: clinical trials
Exploring Blood Plasma Metabolomics: Unraveling the Metabolic Landscape in Treatment-Resistant Adolescent Depression
Conditions: Psychiatric Disorder; Major Depressive Disorder; Metabolic Disorder Interventions: Diagnostic Test: 17-HAMD Sponsors: First Affiliated Hospital of Chongqing Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Implementing and evaluating group interpersonal therapy for postnatal depression in Lebanon and Kenya —individually randomised superiority trial
This study seeks to gauge the potency of g-IPT for women with PND in two LMICs.MethodsThis multi-site randomised controlled trial is a continuation of two preceding phases —conceptual mapping and a feasibility study executed in Lebanon and Kenya. Insights gleaned from these phases underpin this comprehensive RCT, which contrasts the efficacy and cost-effectiveness of high-quality standard care (HQ-SC) augmented with g-IPT against HQ-SC in isolation. The trial, chara cterised as an individually randomised superiority assessment, targets women with postnatal depression in Beirut, Lebanon, and Nairobi, Kenya. It aims to det...
Source: Trials - March 26, 2024 Category: Research Source Type: clinical trials
Acceptability and Feasibility of Transcranial Magnetic Stimulation (TMS) for Depression in Multiple Sclerosis
Conditions: Multiple Sclerosis; Major Depressive Disorder; Treatment Resistant Depression Sponsors: University of Utah Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
Sleep Quality, Cognitive Performance, and Computerized Cognitive Training
Conditions: Bipolar Disorder; Major Depressive Disorder; Psychosis Interventions: Drug: Lurasidone; Drug: FDA Approved antidepressant treatment Sponsors: George West Mental Health Foundation d/b/a Skyland Trail; Sumitomo Pharmaceuticals America Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 25, 2024 Category: Research Source Type: clinical trials
CAPABLE Transplant
Conditions: Quality of Life; Depression; End Stage Renal Disease; Disability Physical Interventions: Behavioral: CAPABLE Transplant- Open Label Pilot; Behavioral: CAPABLE Transplant- Randomized Control Trial Sponsors: Johns Hopkins University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
